PHARMACOECONOMIC ASPECTS OF THE FIRST-LINE BIOLOGIC THERAPIES IN RUSSIAN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Ryazhenov, V. V. [1 ]
Gorokhova, S. G. [1 ]
Emchenko, I., V [1 ]
机构：
[1] IM Sechenov First Moscow State Med Univ, Moscow, Russia
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.1494
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A563 / A563
页数：1
相关论文
共 50 条
  • [1] PHARMACOECONOMIC ANALYSIS OF DIFFERENT STRATEGIES OF MONOTHERAPY WITH BIOLOGIC THERAPIES IN RUSSIAN PATIENTS WITH RHEUMATOID ARTHRITIS
    Ryazhenov, V. V.
    Gorokhova, S. G.
    VALUE IN HEALTH, 2015, 18 (07) : A645 - A645
  • [2] Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis
    Cantini, Fabrizio
    Niccoli, Laura
    Nannini, Carlotta
    Cassara, Emanuele
    Kaloudi, Olga
    Favalli, Ennio Giulio
    Becciolini, Andrea
    Biggioggero, Martina
    Benucci, Maurizio
    Li Gobbi, Francesca
    Grossi, Valentina
    Infantino, Maria
    Meacci, Francesca
    Manfredi, Mariangela
    Guiducci, Serena
    Bellando-Randone, Silvia
    Matucci-Cerinic, Marco
    Foti, Rosario
    Di Gangi, Marcella
    Mosca, Marta
    Tani, Chiara
    Palmieri, Fabrizio
    Goletti, Delia
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2016, 45 (05) : 519 - 532
  • [3] PHARMACOECONOMIC EVALUATION OF BIOLOGIC THERAPIES IN RUSSIAN PATIENTS WITH RHEUMATOID ARTHRITIS AND INTOLERANCE OR INADEQUATE RESPONSE TO CONVENTIONAL BASIC THERAP
    Ryazhenov, V. V.
    Gorokhova, S. G.
    Maximkin, S. A.
    VALUE IN HEALTH, 2014, 17 (07) : 375 - 375
  • [4] RESPIRATORY INFECTIONS IN PATIENTS UNDERGOING FIRST-LINE BIOLOGIC THERAPY FOR RHEUMATOID ARTHRITIS
    Nakamoto, Keitaro
    Saraya, Takeshi
    Sada, Mitsuru
    Inui, Toshiya
    Ogawa, Yukari
    Koide, Takashi
    Takata, Saori
    Watanabe, Masato
    Yokoyama, Takuma
    Kurai, Daisuke
    Ishii, Haruyuki
    Takizawa, Hajime
    RESPIROLOGY, 2015, 20 : 133 - 133
  • [5] COMPARATIVE EFFECTIVENESS OF FIRST-LINE BIOLOGIC MONOTHERAPY IN RHEUMATOID ARTHRITIS
    Silvagni, E.
    Bortoluzzi, A.
    Carrara, G.
    Govoni, M.
    Scire, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 562 - 563
  • [6] High Retention Rates and Clinical Efficacy of Tocilizumab As First-Line Biologic Treatment in Patients with Rheumatoid Arthritis
    Okano, Tadashi
    Inui, Kentaro
    Tada, Masahiro
    Sugioka, Yuko
    Mamoto, Kenji
    Koike, Tatsuya
    Nakamura, Hiroaki
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [7] Predicting Treatment Change in Rheumatoid Arthritis Patients Treated with TNF Inhibitors as First-Line Biologic Agent
    Jin, Yinzhu
    Landon, Joan
    Krueger, Whitney
    Liede, Alexander
    Kim, Seoyoung
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1176 - 1178
  • [8] First-line treatments for rheumatoid arthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2023, 5 (09): : E507 - E507
  • [9] EFFECTIVENESS OF SECOND LINE BIOLOGIC USE IN RHEUMATOID ARTHRITIS AFTER SWITCHING FROM FIRST-LINE BIOLOGICS
    Schabert, V. F.
    Yeaw, J.
    Korn, J.
    Quach, C.
    Harrison, D. J.
    Yun, H.
    Joseph, G.
    Collier, D.
    Curtis, J.
    VALUE IN HEALTH, 2013, 16 (03) : A223 - A223
  • [10] HEALTHCARE COSTS ASSOCIATED WITH SERIOUS INFECTIONS AMONG BIOLOGIC-NAIVE RHEUMATOID ARTHRITIS PATIENTS INITIATING FIRST-LINE BIOLOGIC TREATMENT
    Johnston, S.
    Kelly, S.
    Nadkarni, A.
    Wilson, K.
    Limone, B.
    Hochberg, M.
    INTERNAL MEDICINE JOURNAL, 2015, 45 : 29 - 30
12345